Institutional investors purchased a net $247.3 thousand shares of CLLS during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 26.64% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LONG FOCUS CAPITAL MANAGEMENT LL... Bought 249.3 Thousand shares of Cellectis SA
PRINCIPAL GLOBAL INVESTORS LLC Bought 133.6 Thousand shares of Cellectis SA
HUDSON BAY CAPITAL MANAGEMENT LP Bought 63.5 Thousand shares of Cellectis SA